The Clinical Role of Dual-Time-Point 18F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma

被引：16

作者：

Lee S. ^{[1
]}

Park T. ^{[1
]}

Park S. ^{[1
]}

Pahk K. ^{[2
]}

Rhee S. ^{[2
]}

Cho J. ^{[2
]}

Jeong E. ^{[2
]}

Kim S. ^{[1
]}

Choe J.G. ^{[2
]}

机构：

[1] Departments of Nuclear Medicine, Korea University Guro Hospital, Guro-gu, Seoul, 152-703, # 80, Guro-dong

[2] Departments of Nuclear Medicine, Korea University Anam Hospital, Seoul

来源：

Nuclear Medicine and Molecular Imaging | 2014年 / 48卷 / 2期

关键词：

Delay scan; Dual-phase PET; Dual-time-point imaging; Retention index; SUVmax; Thyroid incidentaloma;

D O I：

10.1007/s13139-013-0247-z

中图分类号：

学科分类号：

摘要：

Thyroid incidentalomas are common findings during imaging studies including 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) for cancer evaluation. Although the overall incidence of incidental thyroid uptake detected on PET imaging is low, clinical attention should be warranted owing to the high incidence of harboring primary thyroid malignancy. We retrospectively reviewed 2,368 dual-time-point 18F-FDG PET/CT cases that were undertaken for cancer evaluation from November 2007 to February 2009, to determine the clinical impact of dual-time-point imaging in the differential diagnosis of thyroid incidentalomas. Focal thyroid uptake was identified in 64 PET cases and final diagnosis was clarified with cytology/histology in a total of 27 patients with 18F-FDG-avid incidental thyroid lesion. The maximum standardized uptake value (SUVmax) of the initial image (SUV1) and SUVmax of the delayed image (SUV2) were determined, and the retention index (RI) was calculated by dividing the difference between SUV2 and SUV1 by SUV1 (i.e., RI = [SUV2 - SUV1]/SUV1 × 100). These indices were compared between patient groups that were proven to have pathologically benign or malignant thyroid lesions. There was no statistically significant difference in SUV1 between benign and malignant lesions. SUV2 and RI of the malignant lesions were significantly higher than the benign lesions. The areas under the ROC curves showed that SUV2 and RI have the ability to discriminate between benign and malignant thyroid lesions. The predictability of dual-time-point PET parameters for thyroid malignancy was assessed by ROC curve analyses. When SUV2 of 3.9 was used as cut-off threshold, malignancy on the pathology could be predicted with a sensitivity of 87.5 % and specificity of 75 %. A thyroid lesion that shows RI greater than 12.5 % could be expected to be malignant (sensitivity 88.9 %, specificity 66.3 %). All malignant lesions showed an increase in SUVmax on the delayed images compared with the initial images. But in the group of benign lesions, 37.5 % (6/16) showed a decrease or no change in SUVmax. Dual-time-point 18F-FDG PET/CT, obtaining additional images 2 h after injection, seems to be a complementary method for the differentiation between malignancy and benignity of incidental thyroid lesions. © 2013 Korean Society of Nuclear Medicine.

引用

页码：121 / 129

页数：8

共 35 条

[1]

Jin J., McHenry C.R., Thyroid incidentaloma, Best Pract Res Clin Endocrinol Metab, 26, 1, pp. 83-96, (2012)

[2]

Kang K.W., Kim S.K., Kang H.S., Lee E.S., Sim J.S., Lee I.G., Et al., Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects, J Clin Endocrinol Metab, 88, 9, pp. 4100-4104, (2003)

[3]

Choi J.Y., Lee K.S., Kim H.J., Shim Y.M., Kwon O.J., Park K., Et al., Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization, J Nucl Med, 47, 4, pp. 609-615, (2006)

[4]

Are C., Hsu J.F., Schoder H., Shah J.P., Larson S.M., Shaha A.R., FDG-PET detected thyroid incidentalomas: need for further investigation?, Ann Surg Oncol, 14, 1, pp. 239-247, (2007)

[5]

Pagano L., Sama M.T., Morani F., Prodam F., Rudoni M., Boldorini R., Et al., Thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance, Clin Endocrinol (Oxf)., 75, 4, pp. 528-534, (2011)

[6]

Cohen M.S., Arslan N., Dehdashti F., Doherty G.M., Lairmore T.C., Brunt L.M., Et al., Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography, Surgery, 130, 6, pp. 941-946, (2001)

[7]

Nilsson I.L., Arnberg F., Zedenius J., Sundin A., Thyroid incidentaloma detected by fluorodeoxyglucose positron emission tomography/computed tomography: practical management algorithm, World J Surg, 35, 12, pp. 2691-2697, (2011)

[8]

Ishimori T., Patel P.V., Wahl R.L., Detection of unexpected additional primary malignancies with PET/CT, J Nucl Med, 46, 5, pp. 752-757, (2005)

[9]

Soelberg K.K., Bonnema S.J., Brix T.H., Hegedus L., Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review, Thyroid, 22, 9, pp. 918-925, (2012)

[10]

Suga K., Kawakami Y., Hiyama A., Sugi K., Okabe K., Matsumoto T., Et al., Differential diagnosis between 18F- FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan, Ann Nucl Med, 23, 6, pp. 523-531, (2009)

← 1 2 3 4 →